02/07/2021
FYI MD most tell you about alternatives to treat pain before prescribing opioids!
During the informed consent process, the physician must go over alternative treatment options. PLEASE READ BELOW: 456.44 Controlled substance prescribing.— (7) NONOPIOID ALTERNATIVES.— (a) The Legislature finds that every competent adult has the fundamental right of self-determination regarding decisions pertaining to his or her own health, including the right to refuse an opioid drug listed as a Schedule II controlled substance in s. 893.03 or 21 U.S.C. s. 812. (b) The department shall develop and publish on its website an educational pamphlet regarding the use of nonopioid alternatives for the treatment of pain. The pamphlet shall, at a minimum, include: 1. Information on available nonopioid alternatives for the treatment of pain, including nonopioid medicinal drugs or drug products and nonpharmacological therapies. 2. The advantages and disadvantages of the use of nonopioid alternatives. (c) Except when a patient is receiving care in a hospital critical care unit or emergency department or a patient is receiving hospice services under s. 400.6095, before providing care requiring the administration of anesthesia involving the use of an opioid drug listed as a Schedule II controlled substance in s. 893.03 or 21 U.S.C. s. 812, or prescribing or ordering an opioid drug listed as a Schedule II controlled substance in s. 893.03 or 21 U.S.C. s. 812 for the treatment of pain, a health care practitioner who prescribes or orders an opioid drug must: 1. Inform the patient or the patient’s representative of available nonopioid alternatives for the treatment of pain, which may include nonopioid medicinal drugs or drug products, interventional procedures or treatments, acupuncture, chiropractic treatments, massage therapy, physical therapy, occupational therapy, or any other appropriate therapy as determined by the health care practitioner. 2. Discuss with the patient or the patient’s representative the advantages and disadvantages of the use of non-opioid alternatives, including whether the patient is at a high risk of, or has a history of, controlled substance abuse or misuse and the patient’s personal preferences. 3. Provide the patient or the patient’s representative with a printed copy of the educational pamphlet described in paragraph (b). 4. Document the nonopioid alternatives considered in the patient’s record. Additional links:https://www.flmedical.org/.../Docs/HB-451-Opioid-article.pdfhttps://www.flmedical.org/Florida/Florida_Public/Docs/HB451_pamphlet_6-28-19-singles.pdf
